Skip to main content
HR 4489 111th Congress House Government Operations and Politics Business records Consumer affairs Government employee pay, benefits, personnel management Health care costs and insurance Prescription drugs Public contracts and procurement

FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act

Introduced: January 21, 2010 Introduced by: Lynch, Stephen F. Democratic · Massachusetts See on congress.gov
 Everywhere this bill has been 7 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 24, 2010
Subcommittee Consideration and Mark-up Session Held.
Mar 24, 2010
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Feb 23, 2010
Subcommittee Hearings Held.
Feb 12, 2010
Referred to the Subcommittee on Federal Workforce, Post Office, and the District of Columbia.
Jan 21, 2010
Introduced in House
Jan 21, 2010
Referred to the House Committee on Oversight and Government Reform.
Jan 21, 2010
Sponsor introductory remarks on measure. (CR E70-71)
 Plain-English summary Congressional Research Service

FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with requirements of this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply.

Prohibits: (1) a pharmaceutical drug manufacturer or retail pharmacy from having a controlling interest in the PBM; or (2) the PBM from having a controlling interest in a retail pharmacy. Requires each carrier to certify PBM compliance annually. Prohibits OPM from permitting a carrier that has a controlling interest in a PBM to earn a profit from such interest with respect to an FEHBP contract.

Sets forth requirements of PBM arrangements under the FEHBP, including regarding: (1) drug substitution restrictions; (2) PBM reimbursement of carriers; (3) sale by a PBM of utilization and claims data; (4) drug pricing and the basis for reimbursement; (5) provisions of an explanation of benefits to enrollees; (6) nondiscriminatory contracts regarding required participation; (7) OPM access to PBM contract information; (8) civil monetary penalties for making false statements or claims to the government; and (9) reports from drug manufacturers on average manufacturer prices for drugs each quarter.

What's happening now March 24, 2010

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

 Committees of jurisdiction 2